168 related articles for article (PubMed ID: 23635842)
21. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case-control study.
Onuigbo MA
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):320-2. PubMed ID: 22238243
[No Abstract] [Full Text] [Related]
22. [ACE inhibitor, ARB, renin inhibitor].
Suzuki J; Higaki J
Nihon Rinsho; 2012 Aug; 70 Suppl 6():253-8. PubMed ID: 23156517
[No Abstract] [Full Text] [Related]
23. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study.
Bajaj RR; Wald R; Hackam DG; Gomes T; Perl J; Juurlink DN; Manno M; Garg AX; Kitchlu A; Mamdani MM; Yan AT
Arch Intern Med; 2012 Apr; 172(7):591-3. PubMed ID: 22493468
[No Abstract] [Full Text] [Related]
24. Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary.
Sato M; Takahashi M; Kario K
J Clin Hypertens (Greenwich); 2021 Mar; 23(3):692-695. PubMed ID: 33492725
[TBL] [Abstract][Full Text] [Related]
25. Reply to the commentary by Onuigbo on the article "Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins. A case-control study".
Moulis G; Sailler L; Montastruc JL
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):900-1. PubMed ID: 22696169
[No Abstract] [Full Text] [Related]
26. Use of angiotensin receptor blockers after angioedema with an angiotensin-converting enzyme inhibitor.
Haymore BR; DeZee KJ
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):83-4. PubMed ID: 19663135
[No Abstract] [Full Text] [Related]
27. Preoperative angiotensin axis blockade therapy, intraoperative hypotension, and the risks of postoperative acute kidney injury.
Onuigbo MA
J Hosp Med; 2014 Sep; 9(9):610. PubMed ID: 24932783
[No Abstract] [Full Text] [Related]
28. New potassium binders reduce the risk of hyperkalaemia in patients treated with renin-angiotensin-aldosterone system inhibitors.
Tamargo M; Tamargo J
Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):193-194. PubMed ID: 29982385
[No Abstract] [Full Text] [Related]
29. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.
Hedner T; Samuelsson O; Lunde H; Lindholm L; Andrén L; Wiholm BE
BMJ; 1992 Apr; 304(6832):941-6. PubMed ID: 1581715
[TBL] [Abstract][Full Text] [Related]
30. In response to "Preoperative angiotensin axis blockade therapy, intraoperative hypotension, and the risks of postoperative acute kidney injury".
Hennrikus E; Mets B
J Hosp Med; 2014 Sep; 9(9):611. PubMed ID: 24932910
[No Abstract] [Full Text] [Related]
31. Repeated subileus due to angioedema during renin-angiotensin system blockade.
Tojo A; Onozato ML; Fujita T
Am J Med Sci; 2006 Jul; 332(1):36-8. PubMed ID: 16845240
[TBL] [Abstract][Full Text] [Related]
32. A Rare Case of Losartan-Induced Visceral Angioedema.
Rosas S; Fowler A; Stodgill E; Deyo-Svendsen M; Phillips M
J Prim Care Community Health; 2023; 14():21501319231213744. PubMed ID: 37965705
[TBL] [Abstract][Full Text] [Related]
33. Renin-Angiotensin-Aldosterone System Inhibitors and the Risk of AKI in COVID-19 Compared with Influenza.
Birkelo BC; Parr SK; Perkins AM; Greevy RA; Arroyo JP; Hung AM; Vincz AJ; Shah SC; Kapoor T; Matheny ME; Siew ED
Clin J Am Soc Nephrol; 2022 Mar; 17(3):423-425. PubMed ID: 35110376
[No Abstract] [Full Text] [Related]
34. Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.
Salvador GL; Marmentini VM; Cosmo WR; Junior EL
Eur J Prev Cardiol; 2017 Dec; 24(18):1914-1924. PubMed ID: 28862020
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
Rasmussen ER; Hallberg P; Baranova EV; Eriksson N; Karawajczyk M; Johansson C; Cavalli M; Maroteau C; Veluchamy A; Islander G; Hugosson S; Terreehorst I; Asselbergs FW; Norling P; Johansson HE; Kohnke H; Syvänen AC; Siddiqui MK; Lang CC; Magnusson PKE; Yue QY; Wadelius C; von Buchwald C; Bygum A; Alfirevic A; Maitland-van der Zee AH; Palmer CNA; Wadelius M
Pharmacogenomics J; 2020 Dec; 20(6):770-783. PubMed ID: 32080354
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema.
Sabroe RA; Black AK
Br J Dermatol; 1997 Feb; 136(2):153-8. PubMed ID: 9068723
[TBL] [Abstract][Full Text] [Related]
37. Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers?
Gavras I; Gavras H
Arch Intern Med; 2003 Jan; 163(2):240-1. PubMed ID: 12546617
[No Abstract] [Full Text] [Related]
38. The right time and "Pl ACE": optimal management of perioperative angiotensin-converting enzyme inhibitors.
Chopra V; Wijeysundera DN
J Hosp Med; 2014 May; 9(5):334-6. PubMed ID: 24799361
[No Abstract] [Full Text] [Related]
39. Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials.
Kow CS; Ming LC; Hasan SS
Hypertens Res; 2021 Aug; 44(8):1042-1045. PubMed ID: 34017093
[No Abstract] [Full Text] [Related]
40. Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
Reichman ME; Wernecke M; Graham DJ; Liao J; Yap J; Chillarige Y; Southworth MR; Keeton S; Goulding MR; Mott K; Kelman JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1190-1196. PubMed ID: 28722207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
